Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT06844734
Eligibility Criteria:
Inclusion Criteria:
* Patients meet the clinical and genetic diagnostic criteria of hereditary spastic paraplegia (HSP);
* Age: 14 to 70 years old
* Modified Ashworth Score for lower limbs: ≥2 joints with muscle tone ≥grade 3
* Patients are willing to participate in clinical trials and able to understand and comply with the research program
Exclusion Criteria:
* Patients are allergic to the baclofen
* Other neurological diseases likely affecting the evaluation of study treatment
* Other medical conditions such as: heart disease, tumor, blood disease, liver disease, kidney disease, etc. in the past 1 year
* Pregnancy or lactating women or subjects who are unable to use appropriate contraception during the trial
* Participating in another study drug trial and used the investigational drug in the past 30 days
* Subjects have poor compliance or other factors that are not suitable for participating in the clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
70 Years
Study:
NCT06844734
Study Brief:
Protocol Section:
NCT06844734